12 May 2023
Patients with aggressive brain tumours may be able to take part in a new trial of a cannabinoid-based drug, coordinated by the University of Birmingham.
04 May 2023
Cancer Research UK Clinical Trials Unit-sponsored trial found new drug better for treating rare cancer for patients not responding to first line treatment
28 October 2022
A UK-based leading clinical trials unit involves patients and members of the public across all areas of its work and is keen to learn how they can do better.
14 October 2022
Renewed National Institute for Health and Care Research Birmingham Biomedical Research Centre continue funds for developments around inflammatory diseases
06 October 2022
Cancer outcomes could improve if we learn lessons from pandemic to accelerate translation of research into practice
15 March 2022
Patients at Great Ormond Street Hospital and Southampton Children's Hospital are taking part in research to work out how they respond to COVID-19 vaccination.
20 December 2021
A proof-of-concept trial has identified a drug that may offer benefit some patients hospitalised with COVID-19 pneumonia.
26 August 2021
A new clinical trial has launched in the UK to determine whether a third vaccine will improve the immune response of people who have weakened immune systems.
24 August 2021
A significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions mount a low or undetectable immune response after two doses of the same COVID-19 vaccine
04 August 2021
The University of Birmingham will co-ordinate a major UK trial to analyse the efficacy of cannabis-based drug Sativex in treating the most aggressive form of brain tumours.